| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 242.476 | 211.844 | 72.235 | 1.847 | 3.309 | 2.877 | 2.608 | 2.516 | 2.321 | 2.093 |
| Total Income - EUR | 242.527 | 212.989 | 73.509 | 1.847 | 3.309 | 2.877 | 2.654 | 2.526 | 2.928 | 2.404 |
| Total Expenses - EUR | 236.463 | 208.674 | 74.294 | 1.837 | 2.045 | 1.969 | 1.913 | 1.377 | 9.618 | 2.434 |
| Gross Profit/Loss - EUR | 6.064 | 4.315 | -785 | 10 | 1.264 | 909 | 741 | 1.149 | -6.690 | -30 |
| Net Profit/Loss - EUR | 5.069 | 3.467 | -1.512 | -45 | 1.164 | 827 | 664 | 1.084 | -6.719 | -64 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Nalvexim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.882 | 10.768 | 10.278 | 9.788 | 9.302 | 8.835 | 8.356 | 8.097 | 7.788 | 7.462 |
| Current Assets | 58.663 | 55.111 | 19.198 | 19.109 | 20.220 | 20.073 | 18.072 | 17.148 | 12.315 | 10.460 |
| Inventories | 34.395 | 25.423 | 2.796 | 2.745 | 2.629 | 2.579 | 0 | 0 | 0 | 0 |
| Receivables | 158 | 197 | 12.609 | 12.395 | 12.037 | 11.801 | 11.526 | 11.605 | 8.593 | 9.557 |
| Cash | 24.110 | 29.491 | 3.792 | 3.968 | 5.554 | 5.693 | 6.546 | 5.543 | 3.722 | 902 |
| Shareholders Funds | 32.978 | 31.092 | 25.645 | 25.129 | 25.807 | 25.003 | 24.303 | 24.797 | 16.922 | 16.764 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 38.568 | 34.787 | 3.831 | 3.767 | 3.716 | 3.906 | 2.124 | 448 | 3.181 | 1.158 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Nalvexim Srl